To go public in the most recent IPO window, a company of either model typically required a lead program in later stages of clinical development, several earlier clinical-stage programs or a ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Successful IPO takeoffs have been spread between small ... August after the company announced a $100 million share buyback program (analysts view share buybacks as a sign that management is ...

Gig-work Platform EPWK Tests Investment Crowds With Upsized IPO Plan An initial public offering (IPO) is a company’s 1st entry into the public stock market. Sometimes referred to as “going pub ...

Three sizable IPOs priced this past week, joined by a flurry of small issuers and blank check companies - Ingram Micro, ...

In the context of a global economic slowdown, heightened market volatility, geopolitical changes, and adjustments in monetary policy, the ...

After a recent slower period of activity in the initial public offering (IPO) markets, there has been speculation in ...

Septerna just entered the clinic, and its lack of human data makes it an outlier among the companies able to successfully go public this year in what is still a cautious biotech IPO market.

Prior to this period, biotech companies typically needed to demonstrate sufficient data (often clinical) and positive program development to successfully launch an IPO. The new dynamic was clear ...

A further $24 million is earmarked for taking its chronic spontaneous urticaria program led by SEP-631 into phase 1. Septerna is joining a renewed trickle of biotech IPOs that began in late summer ...

Madbouly said that most of the discussions with the IMF revolve around how the government can postpone some of the targets not to put pressure on the citizens in the coming period ...

Omada Health's metabolic health program has now become the entry point for most new employers considering contracts with Omada Health, D ...